Growth in Chronic Kidney Disease

Advances in Chronic Kidney Disease

Volumn 18, Issue 5, 2011, Pages 324-331

  Janjua, Halima S ^a   Mahan, John D ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Children; CKD; Growth failure; Recombinant growth hormone

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; RECOMBINANT GROWTH HORMONE;

CHRONIC KIDNEY DISEASE; DIALYSIS; GLOMERULUS FILTRATION RATE; GROWTH DISORDER; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; METABOLIC ACIDOSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CHRONIC DISEASE; GROWTH; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY DISEASES;

EID: 80052412122     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2011.02.005     Document Type: Review

References (42)

1. Furth S.L., Hwang W., Yang C., Neu A.M., Fivush B.A., Powe N.R. Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol 2002, 17:450-455.
2. Furth S.L., Stablein D., Fine R.N., Powe N.R., Fivush B.A. Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 2002, 109:909-913.
3. Tonshoff B., Kiepe D., Ciarmatori S. Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol 2005, 20:279-289.
4. Mahesh S., Kaskel F. Growth hormone axis in chronic kidney disease. Pediatr Nephrol 2008, 23:41-48.
5. Mahan J.D., Warady B.A. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol 2006, 21:917-930.
6. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
7. Roelfsema V., Clark R.G. The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure. J Am Soc Nephrol 2001, 12:1297-1306.
8. Pombo M., Pombo C.M., Garcia A., et al. Hormonal control of growth hormone secretion. Horm Res 2001, 55(suppl 1):11-16.
9. Ulinski T., Mohan S., Kiepe D., et al. Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol 2000, 14:589-597.
10. Tonshoff B., Powell D.R., Zhao D., et al. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia. Endocrinology 1997, 138:938-946.
11. Lee D.Y., Park S.K., Yorgin P.D., Cohen P., Oh Y., Rosenfeld R.G. Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. J Clin Endocrinol Metab 1994, 79:1376-1382.
12. Schaefer F., Chen Y., Tsao T., Nouri P., Rabkin R. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 2001, 108:467-475.
13. Sun D.F., Zheng Z., Tummala P., Oh J., Schaefer F., Rabkin R. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle. J Am Soc Nephrol 2004, 15:2630-2636.
14. Woelfle J., Billiard J., Rotwein P. Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J Biol Chem 2003, 278:22696-22702.
15. Chen Y., Biada J., Sood S., Rabkin R. Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation. Kidney Int 2010, 78:89-95.
16. Rabkin R., Sun D.F., Chen Y., Tan J., Schaefer F. Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling. Pediatr Nephrol 2005, 20:313-318.
17. Lane P.H. Puberty and chronic kidney disease. Adv Chronic Kidney Dis 2005, 12:372-377.
18. Belgorosky A., Ferraris J.R., Ramirez J.A., Jasper H., Rivarola M.A. Serum sex hormone-binding globulin and serum nonsex hormone-binding globulin-bound testosterone fractions in prepubertal boys with chronic renal failure. J Clin Endocrinol Metab 1991, 73:107-110.
19. Schaefer F., Veldhuis J.D., Robertson W.R., Dunger D., Scharer K. Immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic renal failure. Cooperative Study Group on Pubertal Development in Chronic Renal Failure. Kidney Int 1994, 45:1465-1476.
20. Graf L., Candelaria S., Doyle M., Kaskel F. Nutrition assessment and hormonal influences on body composition in children with chronic kidney disease. Adv Chronic Kidney Dis 2007, 14:215-223.
21. Maniar S., Kleinknecht C., Zhou X., Motel V., Yvert J.P., Dechaux M. Growth hormone action is blunted by acidosis in experimental uremia or acid load. Clin Nephrol 1996, 46:72-76.
22. Parekh R.S., Flynn J.T., Smoyer W.E., et al. Improved growth in young children with severe chronic renal insufficiency who use specified nutritional therapy. J Am Soc Nephrol 2001, 12:2418-2426.
23. Boehm M., Riesenhuber A., Winkelmayer W.C., Arbeiter K., Mueller T., Aufricht C. Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease. Pediatr Nephrol 2007, 22:1189-1193.
24. Salusky I.B., Kuizon B.G., Juppner H. Special aspects of renal osteodystrophy in children. Semin Nephrol 2004, 24:69-77.
25. Hochberg Z. Mechanisms of steroid impairment of growth. Horm Res 2002, 58(suppl 1):33-38.
26. Greenbaum L.A., Munoz A., Schneider M.F., et al. The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol 2011, 6:14-21.
27. Busschbach J.J., Rikken B., Grobbee D.E., De Charro F.T., Wit J.M. Quality of life in short adults. Horm Res 1998, 49:32-38.
28. Broyer M., Le Bihan C., Charbit M., et al. Long-term social outcome of children after kidney transplantation. Transplantation 2004, 77:1033-1037.
29. Gerson A.C., Wentz A., Abraham A.G., et al. Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics 2010, 125:e349-357.
30. Kari J.A., Gonzalez C., Ledermann S.E., Shaw V., Rees L. Outcome and growth of infants with severe chronic renal failure. Kidney Int 2000, 57:1681-1687.
31. Wingen A.M., Fabian-Bach C., Schaefer F., Mehls O. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet 1997, 349:1117-1123.
32. Santos F., Moreno M.L., Neto A., et al. Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: results of a multicenter, controlled, randomized, open clinical trial. Clin J Am Soc Nephrol 2010, 5:1190-1197.
33. Vimalachandra D., Hodson E.M., Willis N.S., Craig J.C., Cowell C., Knight J.F. Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev 2006, 3. CD003264.
34. Seikaly M.G., Salhab N., Warady B.A., Stablein D. Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS. Pediatr Nephrol 2007, 22:1195-1204.
35. Greenbaum L.A., Hidalgo G., Chand D., et al. Obstacles to the prescribing of growth hormone in children with chronic kidney disease. Pediatr Nephrol 2008, 23:1531-1535.
36. Nissel R., Lindberg A., Mehls O., Haffner D. Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease. J Clin Endocrinol Metab 2008, 93:1359-1365.
37. Fine R.N., Ho M., Tejani A., Blethen S. Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J Pediatr 2003, 142:539-545.
38. Mauras N., Attie K.M., Reiter E.O., Saenger P., Baptista J. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. J Clin Endocrinol Metab 2000, 85:3653-3660.
39. Koller E.A., Stadel B.V., Malozowski S.N. Papilledema in 15 renally compromised patients treated with growth hormone. Pediatr Nephrol 1997, 11:451-454.
40. Saland J.M., Pierce C.B., Mitsnefes M.M., et al. Dyslipidemia in children with chronic kidney disease. Kidney Int 2010, 78:1154-1163.
41. Ghio L., Damiani B., Garavaglia R., Oppizzi G., Taioli E., Edefonti A. Lipid profile during rhGH therapy in pediatric renal transplant patients. Pediatr Transplant 2002, 6:127-131.
42. Mahan J.D., Warady B.A., Frane J., et al. First-year response to rhGH therapy in children with CKD: a National Cooperative Growth Study Report. Pediatr Nephrol 2010, 25:1125-1130.